Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Material Requirements to Support Gene Therapy Development Clare Blue, Director of Analytical Development at Biogen and James Wilkinson, VP of Sales and Customer Success at Refeyn Manufacturing processes for gene therapy products are generally low yielding compared to production processes for other biologics. The material requir... 1 week ago | 73 mins Upstream Viral Vector Manufacturing: Transfections of Adherent Cultures at Scale Cassie-Marie Peigné, PhD, Polyplus-transfection® and Ann Rossi Bilodeau, PhD, Corning Life Sciences Many cell and gene therapy applications are dependent on viral vectors for recombinant gene delivery. Efficient transfection of a large biomass of cel... 8 months ago | 44 mins Scalable AAV Manufacturing: Addressing Challenges Across the Workflow Chao Yan Liu, Gino Stolfa, Monica Commerford Thermo Fisher Scientific product experts discuss upstream and downstream solutions across the entire workflow. In this webinar, you'll learn about sc... 11 months ago | 85 mins Corning® HYPER Technologies: Compact Solutions for Cell Culture Scale-up Catherine Siler, Ph.D Introduction: 00:00 – 2:28 Requirements for culturing adherent cells: 2:29 – 3:43 HYPER Technology - Specifications and Performance Analysis: 3:44 - 1... 1 year ago | 45 mins Advanced Trends and Tools for Gene Therapy Constanza Curotto This webinar is part of Bioprocess Webinar Series. See other webinars in this series on our webinar page - Advanced Trends and Tools for Immune Cell ... 1 year ago | 38 mins FDA Perspective on Aseptic Process Simulation for Cell Therapy Product Manufa... Dr Lily Koo, Consumer Safety Officer at FDA and Dr Keen Chung, Principal Scientist (Upstream Process) at Pall Biotech FDA Perspective on Aseptic Process Simulation for Cell Therapy Product Manufacturing Presented by Dr Lily Koo, Consumer Safety Officer at Food and Dru... 2 years ago | 82 mins Designing production facilities of the future Geoffrey Hodge, Chief Technical Officer at Unum Therapeutics and Gary Pigeau, Ph.D., Director at GE Healthcare Engineered autologous T cell products have proven to be an extremely promising new therapeutic modality, but they are currently time-consuming and cos... 3 years ago | 87 mins Multiply Your Cells, Not Your Work: How to Upscale Adherent Cells [FR. VERSION] Dr. Nicolas André The Life Sciences Rendez-vous : Bioprocess, Adherent Cells - PART 1/3. Attend our new compact webinars series (30min) in your local language. See Par... 2 years ago | 28 mins Qualification of Raw Materials Used in the Manufacturing of Cellular Therapies Jim Richardson, Sr Scientific Liaison at USP and Horst Ruppach, Ph.D. Scientific Director at Charles River Presented by Jim Richardson, Sr Scientific Liaison at United States Pharmacopeia Dr. Richardson works in the standards pipeline development group wit... 3 years ago | 80 mins The Race for More Cells - Progress and Challenges in Maximizing Cell Densities Amit K Sharma Scientific progress in the cell and gene therapy field will accelerate clinical cell therapy programs in the coming years. As cell therapy trials adva... 2 years ago | 59 mins
